circRNA basic information
circBase ID: hsa_circ_0072309
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): chr5:38523520-38530768:-
Genomic location(hg38): chr5:38523418-38530666:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005061
MONDO name: lung adenocarcinoma
Disease details: lung adenocarcinoma / LUAD
Disease DO ID:
3910
Disease MeSH ID:
C538231
Disease NCIt ID:
C3512
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

serum samples; adjacent non-tumor tissues; cancerous tissues

Cell lines:

BEAS-2B; A549

In vivo animal model:

-

circRNA-disease information
Expression pattern:
DN
Associated gene: -
Associated microRNA: -
Biological function: Knockdown of hsa_circ_0072309 inhibited A549 cell proliferation and promoted apoptosis; the authors suggested an oncogenetic role in lung adenocarcinoma.
Molecular mechanism: Not mechanistically defined; functional assays showed effects on proliferation and apoptosis.
Biological pathway or process:

proliferation (promotes); apoptosis (inhibits)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Transfection; CCK8; ROC Analysis; Survival Analysis

Clinical significance:

Low expression was associated with advanced TNM stage, lymph node metastasis, smoking, diagnostic AUC, and shorter overall survival and disease-free rates.

Description:

hsa_circ_0072309 was down-regulated in lung adenocarcinoma serum and tissues and showed diagnostic and prognostic significance. Lower expression correlated with aggressive clinical features and poorer survival, while knockdown reduced A549 proliferation and promoted apoptosis, suggesting a pro-tumor functional role.

Confidence score:

0.6155

Other information
Title:

Five circRNAs Serve as Potential Diagnostic and Prognostic Biomarkers in Lung Adenocarcinoma.

Journal: Clinical laboratory
Published: 2021
PubMed ID: 34383411
Study type:

combined biological and clinical study

Data availability: -
Code availability: -